Texas · 89th Legislature (2025) · Bill

HB 3785: Relating to labeling requirements for compounded drug products.

In committee Last action April 28, 2025: Failed to receive affirmative vote in comm.

Plain-language summary

HB 3785 is a bill introduced in the Texas House on March 5, 2025. According to its official title, it concerns: Relating to labeling requirements for compounded drug products. Primary sponsor: Barbara Gervin-Hawkins (Democratic). Most recent recorded action (April 28, 2025): Failed to receive affirmative vote in comm.

Sponsors

Primary sponsor: Barbara Gervin-Hawkins (Democratic).